Floor van de Logt1, Andrew S Day. 1. Department of Paediatrics, University of Otago (Christchurch), Christchurch, New Zealand.
Abstract
Inflammatory bowel diseases are incurable conditions that feature gut inflammation. Standard markers have inadequate sensitivity and specificity. S100A12 is a new fecal marker that has promise as a non-invasive indicator of gut inflammation. This article reviews recent studies focusing on S100A12 and highlights the current and potential roles of this biomarker.
Inflammatory bowel diseases are incurable conditions that feature gut inflammation. Standard markers have inadequate sensitivity and specificity. S100A12 is a new fecal marker that has promise as a non-invasive indicator of gut inflammation. This article reviews recent studies focusing on S100A12 and highlights the current and potential roles of this biomarker.
Authors: Kathryn P Haley; Alberto G Delgado; M Blanca Piazuelo; Brittany L Mortensen; Pelayo Correa; Steven M Damo; Walter J Chazin; Eric P Skaar; Jennifer A Gaddy Journal: Infect Immun Date: 2015-05-11 Impact factor: 3.441
Authors: Gian Eugenio Tontini; Maurizio Vecchi; Luca Pastorelli; Markus F Neurath; Helmut Neumann Journal: World J Gastroenterol Date: 2015-01-07 Impact factor: 5.742
Authors: Yan Lu; Li Zhou; Lifeng Liu; Yan Feng; Li Lu; Xiaoyan Ren; Xinqian Dong; Weiwei Sang Journal: Dis Markers Date: 2014-02-11 Impact factor: 3.434